Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System

• Egile Nagusiak: Michele Fusaroli (Egilea), Emanuel Raschi (Egilea), Milo Gatti (Egilea), Fabrizio De Ponti (Egilea), Elisabetta Poluzzi (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: The analysis of pharmacovigilance databases is crucial for the safety profiling of new and repurposed drugs, especially in the COVID-19 era. Traditional pharmacovigilance analyses-based on disproportionality approaches-cannot usually account for the complexity of spontaneous reports of...